Exchange: NASDAQ·Updated 07:52 PM EDT
GHRS logo

GHRS GH Research PLC

$27.94
$0.71
(2.48%)
Today
Closed $27.94
$0.22
(0.79%)
After Hours
Reported EarningsAug 6
Mkt Cap$1.92B
Vol117,667.00

About GHRS

GH Research Plc is a holding company, which engages in the provision of biopharmaceutical products and services. It develops therapeutic products for patients with psychiatric and neurological disorders. The firm develops novel and proprietary 5-Methoxy-N and N-Dimethyltryptamine, or 5-MeO-DMT, therapies. The company was founded by Theis Terwey, Florian Schönharting, and Magnus Halle in 2018 and is headquartered in Dublin, Ireland.
38

Bearish Sentiment

How do you feel about GHRS?

Advertisement|Remove ads.